Pandemic stress linked to long-term rise in alcohol consumption

Alcohol use increased during the COVID-19 pandemic and remained elevated even after the pandemic ended, according to a large nationally representative Keck Medicine of USC study published today in the Annals of Internal Medicine.

Japan approves Daiichi Sankyo-AstraZeneca’s Enhertu

The latest approval is based on data from the Phase II DESTINY-Lung02 trial of Enhertu for treating unresectable advanced or recurrent non-small cell lung cancer.

August 23, 2023

Novartis pays $15M upfront to license Voyager program; Boehringer advances geographic atrophy drug

Plus, news about Jnana Therapeutics, Vaxcyte, C-Further, Genprex, PharmaEssentia, FORUS Therapeutics, Pharma Two B and Hepion: Novartis licenses Voyager program: Voyager will get $15 million

September 6, 2024

New drug targets identified for retinitis pigmentosa therapies

An international team of researchers has identified new drug targets for therapies that could benefit patients with different forms of retinitis pigmentosa and other inherited

October 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.